These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18829780)

  • 41. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
    Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
    Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stimulant medications and attention deficit-hyperactivity disorder.
    Cohen AL; Jhung MA; Budnitz DS
    N Engl J Med; 2006 May; 354(21):2294-5. PubMed ID: 16723627
    [No Abstract]   [Full Text] [Related]  

  • 43. Children's self-reports on perceived effects on taking stimulant medication for ADHD.
    Thorell LB; Dahlström K
    J Atten Disord; 2009 Mar; 12(5):460-8. PubMed ID: 18685139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulants for kids with ADHD--how to proceed safely.
    Ken Mehta S; Jacobs I
    J Fam Pract; 2014 Feb; 63(2):E1-5. PubMed ID: 24527478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac screening prior to stimulant treatment of ADHD: a survey of US-based pediatricians.
    Leslie LK; Rodday AM; Saunders TS; Cohen JT; Wong JB; Parsons SK
    Pediatrics; 2012 Feb; 129(2):222-30. PubMed ID: 22250023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Massive variation in Ritalin prescribing.
    Gainsbury S
    Health Serv J; 2008 Jul; ():5. PubMed ID: 18705035
    [No Abstract]   [Full Text] [Related]  

  • 48. Treating attention-deficit/hyperactivity disorder with a stimulant transdermal patch: the clinical art.
    Arnold LE; Lindsay RL; López FA; Jacob SE; Biederman J; Findling RL; Ramadan Y
    Pediatrics; 2007 Nov; 120(5):1100-6. PubMed ID: 17974748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attention-deficit/hyperactivity disorder: how much responsibility are pediatricians taking?
    Stein RE; Horwitz SM; Storfer-Isser A; Heneghan AM; Hoagwood KE; Kelleher KJ; O'Connor KG; Olson L
    Pediatrics; 2009 Jan; 123(1):248-55. PubMed ID: 19117889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH; Lee YS; Na C; Ahn JY; Chung US; Daniels MA; Haws CA; Renshaw PF
    Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.
    Gruber R
    Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):863-76. PubMed ID: 19836693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parental attitudes and involvement in psychopharmacological treatment for ADHD: a conceptual model.
    dosReis S; Myers MA
    Int Rev Psychiatry; 2008 Apr; 20(2):135-41. PubMed ID: 18386203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic considerations in the treatment of pediatric behavioral issues.
    Theoktisto KM
    Pediatr Nurs; 2009; 35(6):369-74; quiz 374-5. PubMed ID: 20166466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survey of spine surgeons on attitudes regarding osteoporosis and osteomalacia screening and treatment for fractures, fusion surgery, and pseudoarthrosis.
    Dipaola CP; Bible JE; Biswas D; Dipaola M; Grauer JN; Rechtine GR
    Spine J; 2009 Jul; 9(7):537-44. PubMed ID: 19328744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
    Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
    Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.
    Mosholder AD; Gelperin K; Hammad TA; Phelan K; Johann-Liang R
    Pediatrics; 2009 Feb; 123(2):611-6. PubMed ID: 19171629
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors influencing clinicians' decisions to prescribe medication to prevent coronary heart disease.
    Greenfield S; Bryan S; Gill P; Gutridge K; Marshall T
    J Clin Pharm Ther; 2005 Feb; 30(1):77-84. PubMed ID: 15659007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac arrest with pulseless electrical activity associated with methylphenidate in an adolescent with a normal baseline echocardiogram.
    Daly MW; Custer G; McLeay PD
    Pharmacotherapy; 2008 Nov; 28(11):1408-12. PubMed ID: 18957001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medication management of stimulants in pediatric practice settings: a national perspective.
    Hoagwood K; Jensen PS; Feil M; Vitiello B; Bhatara VS
    J Dev Behav Pediatr; 2000 Oct; 21(5):322-31. PubMed ID: 11064959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Community-wide intervention to improve the attention-deficit/hyperactivity disorder assessment and treatment practices of community physicians.
    Epstein JN; Langberg JM; Lichtenstein PK; Mainwaring BA; Luzader CP; Stark LJ
    Pediatrics; 2008 Jul; 122(1):19-27. PubMed ID: 18595982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.